IL-17 fosters an immune-suppressive environment while upregulating pro-inflammatory mediators, thereby increasing tumor cell invasiveness and metastatic potential (Guo et al., 2022; Li et al., 2024b). This evidence concerns the gene IL17A and neoplasm.